Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

NCT01200355 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

113

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: micafungin
DRUG: posaconazole

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]